Householder Group Estate & Retirement Specialist’s Chevron CVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$81K Sell
563
-4,098
-88% -$627K 0.06% 171
2024
Q3
$686K Buy
4,661
+128
+3% +$19.1K 0.2% 103
2024
Q2
$709K Buy
4,533
+2,139
+89% +$341K 0.2% 106
2024
Q1
$378K Sell
2,394
-101
-4% -$15.2K 0.11% 162
2023
Q4
$372K Buy
2,495
+148
+6% +$22.4K 0.12% 155
2023
Q3
$396K Buy
+2,347
New +$379K 0.14% 135
2023
Q1
$686K Buy
+4,203
New +$705K 0.26% 86
2022
Q4
Sell
-5,000
Closed -$718K 478
2022
Q3
$718K Buy
5,000
+389
+8% +$59.3K 0.3% 74
2022
Q2
$668K Buy
4,611
+300
+7% +$49.6K 0.3% 79
2022
Q1
$702K Buy
4,311
+1,179
+38% +$169K 0.28% 95
2021
Q4
$368K Buy
+3,132
New +$356K 0.14% 147

Other funds holding CVX

Householder Group Estate & Retirement Specialist's CVX Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Chevron (CVX) stake by 88% in Q4 2024, selling an estimated $627K and leaving 563 shares worth $81K. The position accounts for 0.06% of the portfolio, ranked #171.

Householder Group Estate & Retirement Specialist first reported a position in CVX in Q4 2021 and has held it in 11 quarters since. The position peaked at $718K in Q3 2022. 3,754 funds tracked by Wall St. Rank hold CVX as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 563 shares of Chevron worth $81K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 4,098 Chevron shares in Q4 2024, an estimated $627K.
  • Chevron made up 0.06% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #171 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Chevron in Q4 2021 and has held it in 11 quarters since.
  • Householder Group Estate & Retirement Specialist's Chevron position peaked at $718K in Q3 2022.
  • 3,754 funds tracked by Wall St. Rank held Chevron as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.